Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supersitol
- Development stage
- Unknown
- Lead developer
- Jwell Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Supersitol is a fixed-dose combination nutritional supplement developed by Jwell Pharmaceuticals, specifically formulated for prenatal supplementation and the management of reproductive health conditions such as Polycystic Ovary Syndrome (PCOS). The product contains a synergistic blend of myo-inositol and D-chiro-inositol, which function as insulin sensitizers to improve metabolic and ovulatory functions. It is further enriched with N-acetyl L-cysteine (NAC) for its antioxidant properties, Vitamin D3 (cholecalciferol) for bone and immune support, chromium to enhance glucose metabolism, and folic acid to support DNA synthesis and prevent neural tube defects. This oral formulation is designed to address hormonal imbalances and nutritional deficiencies in women during the preconception and prenatal periods.
- Brand names
- Supersitol
- Other names
- D-Chiro-Inositol, N-Acetyl L-Cysteine, Myo Inositol, Cholecalciferol (Vit. D3), Chromium, Folic Acid Tablets
02
Targets
INSR (Insulin receptor)VDR (Vitamin D receptor)DNA
Beyond the preview
Go deeper on Supersitol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Supersitol.